Targeting anti-apoptotic BCL2 family proteins in haematological malignancies - from pathogenesis to treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting anti-apoptotic BCL2 family proteins in haematological malignancies - from pathogenesis to treatment

Published:2017-04-27 Issue:3 Volume:178 Page:364-379
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Vogler Meike¹²,Walter Harriet S.³,Dyer Martin J. S.³

Affiliation:

1. Department of Molecular and Cell Biology; University of Leicester; Leicester UK

2. Institute for Experimental Cancer Research in Paediatrics; Goethe-University; Frankfurt Germany

3. Ernest and Helen Scott Haematological Research Institute; University of Leicester; Leicester UK

Funder

Scott-Waudby Charitable Trust

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14684/fullpdf

Reference96 articles.

1. A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo;Abulwerdi;Molecular Cancer Therapeutics,2014

2. The Bcl-2 apoptotic switch in cancer development and therapy;Adams;Oncogene,2007

3. Pharmacokinetic evaluation of oblimersen sodium for the treatment of chronic lymphocytic leukemia;Advani;Expert Opinion on Drug Metabolism & Toxicology,2011

4. Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides;Aichberger;Blood,2005

5. Multiple BH3 mimetics antagonize antiapoptotic MCL1 protein by inducing the endoplasmic reticulum stress response and up-regulating BH3-only protein NOXA;Albershardt;The Journal of Biological Chemistry,2011

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of bromodomain and extra-terminal proteins targets constitutively active NFκB and STAT signaling in lymphoma and influences the expression of the antiapoptotic proteins BCL2A1 and c-MYC;Cell Communication and Signaling;2024-08-27

2. The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax;Hemato;2024-08-27

3. Identifying Targetable Vulnerabilities to Circumvent or Overcome Venetoclax Resistance in Diffuse Large B-Cell Lymphoma;Cancers;2024-06-03

4. Dysregulation of BCL-2 family proteins in blood neoplasm: therapeutic relevance of antineoplastic agent venetoclax;Exploration of Medicine;2024-05-10

5. BCL2 inhibition: back to the future!;Blood;2024-05-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3